JP2008520687A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520687A5 JP2008520687A5 JP2007543219A JP2007543219A JP2008520687A5 JP 2008520687 A5 JP2008520687 A5 JP 2008520687A5 JP 2007543219 A JP2007543219 A JP 2007543219A JP 2007543219 A JP2007543219 A JP 2007543219A JP 2008520687 A5 JP2008520687 A5 JP 2008520687A5
- Authority
- JP
- Japan
- Prior art keywords
- neural stem
- neurons
- population
- stem cell
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 16
- 210000004027 cell Anatomy 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 230000021164 cell adhesion Effects 0.000 claims description 2
- 210000001178 neural stem cell Anatomy 0.000 claims 9
- 210000002569 neuron Anatomy 0.000 claims 7
- 241000124008 Mammalia Species 0.000 claims 4
- 239000003102 growth factor Substances 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- 210000000278 spinal cord Anatomy 0.000 claims 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims 1
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 claims 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 101710098940 Pro-epidermal growth factor Proteins 0.000 claims 1
- 102000006747 Transforming Growth Factor alpha Human genes 0.000 claims 1
- 101800004564 Transforming growth factor alpha Proteins 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- 210000004700 fetal blood Anatomy 0.000 claims 1
- 230000001605 fetal effect Effects 0.000 claims 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 1
- 210000001161 mammalian embryo Anatomy 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62922004P | 2004-11-17 | 2004-11-17 | |
| US60/629,220 | 2004-11-17 | ||
| PCT/US2005/041631 WO2006055685A2 (en) | 2004-11-17 | 2005-11-17 | Transplantation of human neural cells for treatment of neurodegenerative conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020641A Division JP5805551B2 (ja) | 2004-11-17 | 2012-02-02 | 神経変性状態を治療するためのヒト神経細胞の移植 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008520687A JP2008520687A (ja) | 2008-06-19 |
| JP2008520687A5 true JP2008520687A5 (enExample) | 2012-03-22 |
| JP5424559B2 JP5424559B2 (ja) | 2014-02-26 |
Family
ID=36407743
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543219A Expired - Fee Related JP5424559B2 (ja) | 2004-11-17 | 2005-11-17 | 神経変性状態を治療するためのヒト神経細胞の移植 |
| JP2012020641A Expired - Fee Related JP5805551B2 (ja) | 2004-11-17 | 2012-02-02 | 神経変性状態を治療するためのヒト神経細胞の移植 |
| JP2014262195A Expired - Fee Related JP5981526B2 (ja) | 2004-11-17 | 2014-12-25 | 神経変性状態を治療するためのヒト神経細胞の移植 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020641A Expired - Fee Related JP5805551B2 (ja) | 2004-11-17 | 2012-02-02 | 神経変性状態を治療するためのヒト神経細胞の移植 |
| JP2014262195A Expired - Fee Related JP5981526B2 (ja) | 2004-11-17 | 2014-12-25 | 神経変性状態を治療するためのヒト神経細胞の移植 |
Country Status (13)
| Country | Link |
|---|---|
| US (6) | US7691629B2 (enExample) |
| EP (2) | EP1814979B1 (enExample) |
| JP (3) | JP5424559B2 (enExample) |
| KR (2) | KR101505347B1 (enExample) |
| CN (2) | CN101084303A (enExample) |
| ES (1) | ES2537004T3 (enExample) |
| HK (1) | HK1202238A1 (enExample) |
| IL (2) | IL183092A (enExample) |
| IN (1) | IN2014CN03629A (enExample) |
| NO (1) | NO340914B1 (enExample) |
| PH (1) | PH12015501195B1 (enExample) |
| RU (2) | RU2434636C2 (enExample) |
| WO (1) | WO2006055685A2 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7838292B1 (en) * | 2001-03-29 | 2010-11-23 | University Of Louisville Research Foundation, Inc. | Methods for obtaining adult human olfactory progenitor cells |
| US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
| US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
| JP5424559B2 (ja) | 2004-11-17 | 2014-02-26 | ニューラルステム・インコーポレーテッド | 神経変性状態を治療するためのヒト神経細胞の移植 |
| AU2006220696B2 (en) | 2005-03-07 | 2010-08-19 | Sanbio, Inc. | Use of neuronal precursor cells for treatment of central nervous system lesions |
| GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
| WO2010071864A1 (en) | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Treatment of lung and pulmonary diseases and disorders |
| WO2010071862A1 (en) * | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
| GB0902034D0 (en) * | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
| US10386360B2 (en) | 2009-03-13 | 2019-08-20 | University Of Central Florida Research Foundation, Inc. | Bio-microelectromechanical system transducer and associated methods |
| WO2010111663A1 (en) | 2009-03-26 | 2010-09-30 | Ethicon, Inc. | Human umbilical cord tissue cells as therapy for alzheimer' s disease |
| US8815584B1 (en) | 2009-04-23 | 2014-08-26 | University Of Central Florida Research Foundation, Inc. | Method of co-culturing mammalian muscle cells and motoneurons |
| US9163216B1 (en) | 2009-04-23 | 2015-10-20 | University Of Central Florida Research Foundation, Inc. | Method for culturing skeletal muscle for tissue engineering |
| US8828721B1 (en) | 2009-05-28 | 2014-09-09 | University Of Central Florida Research Foundation, Inc. | Method of myelinating isolated motoneurons |
| US9404140B1 (en) | 2009-11-03 | 2016-08-02 | The University Of Central Florida Research Foundation, Inc. | Patterned cardiomyocyte culture on microelectrode array |
| WO2011097574A1 (en) | 2010-02-05 | 2011-08-11 | University Of Central Florida Research Foundation, Inc. | Model and methods for identifying points of action in electrically active cells |
| CA2798777C (en) | 2010-04-23 | 2016-09-06 | University Of Central Florida Research Foundation, Inc. | Formation of neuromuscular junctions in a defined system |
| MX341316B (es) * | 2010-07-28 | 2016-08-15 | Neuralstem Inc * | Poblacion de celulas madre neurales para tratar y/o revertir enfermedades y/o trastornos neurodegenerativos. |
| US9498554B2 (en) | 2012-07-24 | 2016-11-22 | S.C. Johnson & Son, Inc. | Dispensing device |
| WO2014028940A1 (en) | 2012-08-17 | 2014-02-20 | University Of Central Florida Research Foundation, Inc. | Methods, systems and compositions for functional in vitro cellular models of mammalian systems |
| US10357517B1 (en) | 2012-10-01 | 2019-07-23 | University Of South Florida | Methods of treating epilepsy using neural stem cells that express nanog, SSEA-4, OCT-4, MIR-34B, MIR-34C and MIR-592 |
| RU2515475C1 (ru) * | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| US10694747B2 (en) | 2012-11-21 | 2020-06-30 | S. C. Johnson & Son, Inc. | Dispenser comprising only one single hinge |
| EP2951281B1 (en) | 2013-01-30 | 2018-06-27 | University of Central Florida Research Foundation, Inc. | System and method for mimicking heart function |
| WO2014138003A1 (en) * | 2013-03-04 | 2014-09-12 | Neuralstem, Inc. | Compositions comprising an immunosuppressive drug and/or neural stem cells and methods of using same for the treatment of neurodegenerative diseases and/or disorders |
| WO2014176606A1 (en) | 2013-04-26 | 2014-10-30 | Memorial Sloan-Kettering Center Center | Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells |
| CN104278008B (zh) | 2013-07-12 | 2020-08-21 | 北京宏冠再生医学科技有限公司 | 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途 |
| CA2953376C (en) * | 2014-06-27 | 2024-02-06 | Angiocrine Bioscience, Inc. | Neural cells expressing adenovirus e4orf1, and methods of making and using the same |
| KR101675123B1 (ko) * | 2014-06-27 | 2016-11-14 | 연세대학교 산학협력단 | Psa-ncam-양성 신경전구세포를 유효성분으로 포함하는 허혈성 질환 또는 신경염증 질환 치료용 조성물 |
| US10935541B2 (en) | 2014-08-07 | 2021-03-02 | University Of Central Florida Research Foundation, Inc. | Devices and methods comprising neuromuscular junctions |
| CA2964927C (en) | 2014-10-20 | 2019-07-30 | Neuralstem, Inc. | Stable neural stem cells comprising an exogenous polynucleotide coding for a growth factor and methods of use thereof |
| US10286009B2 (en) * | 2015-05-16 | 2019-05-14 | Asterias Biotherapeutics, Inc. | Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury |
| US11028369B2 (en) | 2015-08-13 | 2021-06-08 | Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. | Induced extended pluripotent stem cells, method of making and using |
| US20190282624A1 (en) | 2015-11-30 | 2019-09-19 | Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. | Improved methods for reprograming non-pluripotent cells into pluripotent stem cells |
| US11007228B2 (en) * | 2016-02-05 | 2021-05-18 | Kyungpook National University Industry-Academic Cooperation Foundation | Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease |
| WO2017173064A1 (en) | 2016-03-30 | 2017-10-05 | Asterias Biotherapeutics, Inc. | Oligodendrocyte progenitor cell compositions |
| FR3058892B1 (fr) * | 2016-11-23 | 2021-04-09 | Univ Bordeaux | Unite de tissu neural et utilisation d'une telle unite pour l'implantation dans le systeme nerveux d'un mammifere |
| CN106619722A (zh) * | 2016-12-05 | 2017-05-10 | 上海安集协康生物技术股份有限公司 | 一种治疗脑部损伤类疾病的神经干细胞注射液 |
| JP6500051B2 (ja) * | 2017-03-17 | 2019-04-10 | 哲丸 村田 | 組織処理方法 |
| US12018278B2 (en) | 2017-05-31 | 2024-06-25 | Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. | Methods for chemically induced lineage reprogramming |
| US12365872B2 (en) | 2018-09-19 | 2025-07-22 | Lineage Cell Therapeutics, Inc. | Methods for differentiating pluripotent stem cells in dynamic suspension culture |
| EP3914264A4 (en) | 2019-01-23 | 2022-11-23 | Asterias Biotherapeutics, Inc. | OLIGODENDROCYTE PROGENITOR CELLS DERIVED FROM THE BACK FROM HUMAN PLURIPOTENT STEM CELLS |
| CN111494422B (zh) * | 2019-01-29 | 2022-04-29 | 中国科学院遗传与发育生物学研究所 | 治疗脊髓损伤的产品及其应用 |
| JP7015605B2 (ja) | 2019-12-27 | 2022-02-03 | 株式会社Rainbow | 頭蓋内に安全に細胞を投与するための総合システム |
| CN115166260B (zh) * | 2022-07-11 | 2023-06-13 | 东南大学 | 血浆脑细胞来源外泌体中维生素d结合蛋白在诊断抑郁症中的应用 |
| CN118064356A (zh) | 2022-11-22 | 2024-05-24 | 浙江霍德生物工程有限公司 | 前脑神经前体细胞在治疗与前脑神经细胞的死亡和/或功能不全相关的疾病中的应用 |
| AU2024343386B2 (en) | 2023-11-03 | 2025-12-18 | Axent Biosciences Inc. | Thermoreversible polymers with improved stability and methods and uses thereof |
Family Cites Families (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0233838A3 (en) | 1986-02-04 | 1990-01-31 | Incyte Pharmaceuticals, Inc. | Neurite-promoting factor and process for the manufacture thereof |
| US4753635A (en) * | 1986-05-23 | 1988-06-28 | Jacqueline Sagen | Inducing analgesia by implantation of cells releasing neuroactive substances |
| NZ226750A (en) * | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
| CA1341469C (en) * | 1988-08-04 | 2004-12-28 | Robert Lindsay Williams | In vitro propagation of embryonic stem cells |
| US5082670A (en) * | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
| US4980174A (en) * | 1988-12-23 | 1990-12-25 | Jacqueline Sagen | Method for alleviating depression |
| WO1991002003A1 (en) | 1989-08-04 | 1991-02-21 | Board Of Regents, The University Of Texas System | Methods and compositions; purified preparation of neural progenitor regulatory factor |
| US5411883A (en) * | 1989-12-26 | 1995-05-02 | Somatix Therapy Corporation | Proliferated neuron progenitor cell product and process |
| WO1991009936A1 (en) | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
| US5196315A (en) | 1990-05-01 | 1993-03-23 | The Johns Hopkins University | Human neuronal cell line |
| US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
| US5981165A (en) * | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | In vitro induction of dopaminergic cells |
| US6071889A (en) * | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
| EP0594669B9 (en) | 1991-07-08 | 2008-03-19 | NeuroSpheres Holdings Ltd. | Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
| US7361505B1 (en) * | 1991-07-08 | 2008-04-22 | Neurospheres Holdings Ltd. | Multipotent neural stem cell compositions |
| US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| US6497872B1 (en) * | 1991-07-08 | 2002-12-24 | Neurospheres Holdings Ltd. | Neural transplantation using proliferated multipotent neural stem cells and their progeny |
| US6399369B1 (en) * | 1991-07-08 | 2002-06-04 | Neurospheres Holdings Ltd. | Multipotent neural stem cell cDNA libraries |
| US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| US6294346B1 (en) * | 1991-07-08 | 2001-09-25 | Neurospheres Holdings, Ltd. | Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents |
| US5175103A (en) * | 1991-10-21 | 1992-12-29 | Trustees Of University Of Pennsylvania | Preparation of pure cultures of post-mitotic human neurons |
| JP4101284B2 (ja) | 1991-11-22 | 2008-06-18 | ジェネンテック・インコーポレーテッド | 神経損傷を改善するｔｇｆ−ｂｅｔａ |
| US5849553A (en) * | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
| AU678988B2 (en) | 1992-07-27 | 1997-06-19 | California Institute Of Technology | Mammalian multipotent neural stem cells |
| US5589376A (en) * | 1992-07-27 | 1996-12-31 | California Institute Of Technology | Mammalian neural crest stem cells |
| US5672499A (en) * | 1992-07-27 | 1997-09-30 | California Institute Of Technology | Immoralized neural crest stem cells and methods of making |
| WO1994003199A1 (en) | 1992-08-04 | 1994-02-17 | Regeneron Pharmaceuticals, Inc. | Method of enhancing differentiation and survival of neuronal precursor cells |
| WO1994004675A2 (en) | 1992-08-19 | 1994-03-03 | Richard Kroczek | Dna sequence encoding a novel member of the steroid and thyroid hormone receptor family |
| ES2194016T5 (es) | 1992-10-28 | 2007-11-16 | Neurospheres Holdings Ltd. | Factores biologicos y celulas germinales neurales. |
| CN1141058A (zh) | 1993-11-09 | 1997-01-22 | 纽罗斯菲里斯控股有限公司 | 中枢神经系统干细胞的原位修饰和处理 |
| CA2200709A1 (en) | 1994-09-23 | 1996-03-28 | Samuel Weis | In vitro models of cns function and dysfunction |
| EP0792350A1 (en) | 1994-11-14 | 1997-09-03 | Neurospheres Holdings Ltd. | Regulation of neural stem cell proliferation |
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5735505A (en) * | 1995-04-03 | 1998-04-07 | Data Connections, Inc. | Cable pulley device and method |
| US5753505A (en) | 1995-07-06 | 1998-05-19 | Emory University | Neuronal progenitor cells and uses thereof |
| US5770414A (en) * | 1996-02-20 | 1998-06-23 | The Regents Of The University Of California | Regulatable retrovirus system for genetic modification of cells |
| US5753506A (en) * | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
| JP3467154B2 (ja) * | 1996-10-14 | 2003-11-17 | パロマ工業株式会社 | 吸収式空調機 |
| WO1998048001A1 (en) | 1997-04-24 | 1998-10-29 | California Institute Of Technology | Methods for differentiating neural stem cells |
| AU755657B2 (en) | 1997-07-04 | 2002-12-19 | University Of Utah Research Foundation | Lineage-restricted neuronal precursors |
| US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
| US5932473A (en) * | 1997-09-30 | 1999-08-03 | Becton Dickinson And Company | Preparation of a cell culture substrate coated with poly-D-lysine |
| US5958767A (en) * | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
| AU755849B2 (en) * | 1998-09-22 | 2002-12-19 | Neuralstem Biopharmaceuticals, Ltd. | Stable neural stem cell lines |
| US6284539B1 (en) * | 1998-10-09 | 2001-09-04 | Neuralstem Biopharmaceuticals, Ltd. | Method for generating dopaminergic cells derived from neural precursors |
| US6531464B1 (en) * | 1999-12-07 | 2003-03-11 | Inotek Pharmaceutical Corporation | Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
| HN2001000224A (es) * | 2000-10-19 | 2002-06-13 | Pfizer | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. |
| ATE349446T1 (de) * | 2001-04-23 | 2007-01-15 | Univ Pennsylvania | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel |
| WO2003000852A2 (en) | 2001-06-22 | 2003-01-03 | The University Of Texas System | Method of producing region-specific neurons from human neuronal stem cells |
| UA74912C2 (en) * | 2001-07-06 | 2006-02-15 | Merck & Co Inc | Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes |
| AU2002360424A1 (en) * | 2001-11-26 | 2003-06-10 | Advanced Cell Technology, Inc. | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| WO2004072264A2 (en) * | 2003-02-12 | 2004-08-26 | Johns Hopkins University School Of Medicine | Fate determination by hes 1 in hematopoietic stem-progenitor cells and uses thereof |
| JP5424559B2 (ja) * | 2004-11-17 | 2014-02-26 | ニューラルステム・インコーポレーテッド | 神経変性状態を治療するためのヒト神経細胞の移植 |
| WO2008002250A1 (en) | 2006-06-30 | 2008-01-03 | Elena Kozlova | Improved stem cells for transplantation and methods for production thereof |
| MX341316B (es) * | 2010-07-28 | 2016-08-15 | Neuralstem Inc * | Poblacion de celulas madre neurales para tratar y/o revertir enfermedades y/o trastornos neurodegenerativos. |
-
2005
- 2005-11-17 JP JP2007543219A patent/JP5424559B2/ja not_active Expired - Fee Related
- 2005-11-17 KR KR1020137020263A patent/KR101505347B1/ko not_active Expired - Lifetime
- 2005-11-17 EP EP05851748.3A patent/EP1814979B1/en not_active Expired - Lifetime
- 2005-11-17 CN CNA2005800394500A patent/CN101084303A/zh active Pending
- 2005-11-17 WO PCT/US2005/041631 patent/WO2006055685A2/en not_active Ceased
- 2005-11-17 CN CN201410240718.8A patent/CN104042629A/zh active Pending
- 2005-11-17 KR KR1020077012097A patent/KR101429284B1/ko not_active Expired - Fee Related
- 2005-11-17 EP EP15156823.5A patent/EP2913393B8/en not_active Expired - Lifetime
- 2005-11-17 US US11/281,640 patent/US7691629B2/en active Active
- 2005-11-17 ES ES05851748.3T patent/ES2537004T3/es not_active Expired - Lifetime
- 2005-11-17 RU RU2007122507/14A patent/RU2434636C2/ru not_active IP Right Cessation
- 2005-11-17 IN IN3629CHN2014 patent/IN2014CN03629A/en unknown
-
2007
- 2007-05-09 IL IL183092A patent/IL183092A/en active IP Right Grant
- 2007-06-15 NO NO20073078A patent/NO340914B1/no not_active IP Right Cessation
-
2009
- 2009-03-16 US US12/404,841 patent/US8460651B2/en not_active Expired - Fee Related
-
2010
- 2010-02-22 US US12/710,097 patent/US8236299B2/en not_active Expired - Fee Related
- 2010-03-08 IL IL204356A patent/IL204356A/en active IP Right Revival
-
2011
- 2011-07-28 RU RU2011131830/15A patent/RU2011131830A/ru not_active Application Discontinuation
-
2012
- 2012-02-02 JP JP2012020641A patent/JP5805551B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-09 US US13/890,787 patent/US9220730B2/en not_active Expired - Lifetime
-
2014
- 2014-12-25 JP JP2014262195A patent/JP5981526B2/ja not_active Expired - Fee Related
-
2015
- 2015-03-17 HK HK15102713.5A patent/HK1202238A1/xx unknown
- 2015-05-28 PH PH12015501195A patent/PH12015501195B1/en unknown
- 2015-11-30 US US14/954,105 patent/US9744194B2/en not_active Expired - Fee Related
-
2017
- 2017-07-27 US US15/661,281 patent/US10286010B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008520687A5 (enExample) | ||
| Takahashi et al. | Harvest of quality-controlled bovine myogenic cells and biomimetic bovine muscle tissue engineering for sustainable meat production | |
| EP2274419B1 (en) | Methods for producing hair microfollicles and de novo papillae and their use for in vitro tests and in vivo implantations | |
| Salvat et al. | Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage | |
| IL256512A (en) | A process for making red blood cells using immortal hematopoietic stem cells and erythropoietin | |
| JP2022105142A (ja) | 哺乳動物種における誘導組織再生のための組成物および方法 | |
| KR20190143830A (ko) | 탈세포화된 뇌조직 매트릭스 기반 뇌 오가노이드 배양용 조성물 및 이의 제조방법 | |
| CN102186969A (zh) | 由人多能干细胞制备人皮肤替代品的方法 | |
| RU2010103046A (ru) | Культивирование отдельных плюрипотентных стволовых клеток | |
| US7186558B2 (en) | Keratinocytes obtained from embryonic stem cells of mammals | |
| JP6744665B2 (ja) | 動物細胞組成物の培養方法、それを用いた動物細胞組成物の製造方法、及び動物細胞組成物 | |
| Ghaedi et al. | Bottom-up signaling from HGF-containing surfaces promotes hepatic differentiation of mesenchymal stem cells | |
| Wang et al. | Effects of astrocytes on neuronal attachment and survival shown in a serum-free co-culture system | |
| Bhatia et al. | Introduction to Pharmaceutical Biotechnology, Volume 3: Animal tissue culture and biopharmaceuticals | |
| WO2009080794A1 (en) | Method for preparing cell-specific extracellular matrices | |
| CN101186900B (zh) | 一种由源于虹彩组织的神经干细胞生产网膜神经细胞的方法 | |
| Kakehi et al. | Repeated and long-term cryopreservation of primary bovine myogenic cells to maintain quality in biomimetic cultured meat | |
| JP3093974B2 (ja) | 神経細胞用培養液、その製造方法及びこれを用いる神経細胞の培養方法 | |
| Yoshida et al. | Morphology and functionality in biomimetic cultured meat produced from various cellular origins | |
| Yamazoe et al. | Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers | |
| EP2845899B1 (en) | Method for preparing dopaminergic neuron-like cell cluster | |
| Mahoney et al. | Cultures of cells from fetal rat brain: methods to control composition, morphology, and biochemical activity | |
| Lee et al. | Vero cells, but not oviductal cells, increase the hatching frequency and total cell count of mouse blastocysts partly by changing energy substrate concentrations in culture medium. | |
| CN1884494A (zh) | 诱导人胚胎干细胞向肝脏细胞分化的方法及其专用培养基 | |
| JP6874953B2 (ja) | ヒトｉＰＳ細胞から、ヒト歯原性上皮細胞やヒト歯原性間葉細胞を製造する方法 |